Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Be687c0e7fe1c8b240c28ba14cf0e5d37> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Be687c0e7fe1c8b240c28ba14cf0e5d37 NCIT_P378 "NCI" @default.
- Be687c0e7fe1c8b240c28ba14cf0e5d37 type Axiom @default.
- Be687c0e7fe1c8b240c28ba14cf0e5d37 annotatedProperty IAO_0000115 @default.
- Be687c0e7fe1c8b240c28ba14cf0e5d37 annotatedSource NCIT_C156249 @default.
- Be687c0e7fe1c8b240c28ba14cf0e5d37 annotatedTarget "An orally bioavailable and selective inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities. Upon oral administration, lisaftoclax targets, binds to and inhibits the activity of Bcl-2. This restores apoptotic processes in tumor cells. Bcl-2 is overexpressed in many cancers and plays an important role in the negative regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival." @default.